Lumen Bioscience Hacks Spirulina to Generate Biologics

by admin | May 17, 2022 | Press Release

Read more

BARDA and Lumen Bioscience partner on a rapidly scalable novel manufacturing platform to develop an intranasal antibody cocktail to treat COVID-19

by admin | Apr 27, 2022 | Press Release

Read more

When Free Markets Fail… and Maybe You Die

by admin | Apr 25, 2022 | Press Release

Read more

Trial Set for Gut Infection Biologic Treatment

by admin | Apr 18, 2022 | Press Release

Read more

Lumen Bioscience Announces Clinical Advancement of LMN-201 for C. difficile Infection

by admin | Apr 15, 2022 | Press Release

— FDA clearance of investigational new drug (IND) application — Initiation of multisite Phase 2 study in spring 2022 — Phase 1 pharmacokinetic study completed Seattle, WA, April 18, 2022 – Lumen Bioscience, a clinical-stage biotechnology company developing biologic...

Lumen Bioscience: Spirulina-based platform enables rapid, low-cost development of oral biologics

by admin | Apr 7, 2022 | Press Release

Read more